Flucloxacillin in Cellulitis: A randomised controlled trial comparing continuous infusion to bolus dosing for uncomplicated cellulitis.

Phase 4

• Conditions: Cellulitis; Skin - Other skin conditions; Infection - Other infectious diseases; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12610000682044
• Lead Sponsor: Royal Brisbane & Women's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-08-18
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Patients with cellulitis felt to be clinically suitable for management in an Emergency Department Short Stay Unit.

Exclusion Criteria

Abbreviated Mortality in Emergency Department Sepsis Score >4
Physician intends to treat with other than Flucloxacillin 2G Intravenously four times daily
Patient has any of the following comorbidities:
*Diabetes Mellitus
*Chronic Systemic Steroid Use
*Immunosuppression
Patient will not be contactable by telephone for next 31 days

Study & Design

• Study Type: Interventional
• Study Design: Not specified